Performance of the 2013 American college of rheumatology/European league against rheumatism Classification criteria for systemic sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease

Journal of Rheumatology

Volumn 42, Issue 1, 2015, Pages 60-63

  Hoffmann Vold, Anna Maria ^a,b   Gunnarsson, Ragnar ^a,b   Garen, Torhild ^a   Midtvedt, Øyvind ^a   Molberg, Øyvind ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Autoimmune diseases; Connective tissue diseases; Epidemiology; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; COHORT ANALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE DURATION; FEMALE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MIXED CONNECTIVE TISSUE DISEASE; SCLERODERMA; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; SYSTEMIC SCLEROSIS; TELANGIECTASIA; UNIVERSITY HOSPITAL; AGED; CLASSIFICATION; LONGITUDINAL STUDY; MIDDLE AGED; RHEUMATOLOGY; SCLERODERMA, SYSTEMIC; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; RHEUMATOLOGY; SCLERODERMA, SYSTEMIC; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84920400485     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.140047     Document Type: Article

References (21)

1. Wigley FM, Denton C. Scleroderma: from pathogenesis to comprehensive management. 1st ed. New York, Dordrecht, Heidelberg, London: Springer; 2012.
2. Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005;35:35-42.
3. Steen V, Domsic RT, Lucas M, Fertig N, Medsger TA Jr. A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis. Arthritis Rheum 2012;64:2986-94.
4. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
5. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
6. Van den Hoogen KD, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci M, et al. Classification criteria for systemic sclerosis; preliminary results [abstract]. Ann Rheum Dis 2013;72 Suppl 3:59.
7. Hoffmann-Vold AM, Molberg O, Midtvedt O, Garen T, Gran JT. Survival and causes of death in an unselected and complete cohort of Norwegian patients with systemic sclerosis. J Rheumatol 2013;40:1127-33.
8. Pope JE. The diagnosis and treatment of Raynaud's phenomenon: A practical approach. Drugs 2007;67:517-25.
9. Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, et al. Interstitial lung disease in systemic sclerosis: A simple staging system. Am J Respir Crit Care Med 2008; 177:1248-54.
10. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-537.
11. Gunnarsson R, Molberg O, Gilboe IM, Gran JT. The prevalence and incidence of mixed connective tissue disease: A national multicentre survey of Norwegian patients. Ann Rheum Dis 2011;70:1047-51.
12. Gunnarsson R, Aalokken TM, Molberg O, Lund MB, Mynarek GK, Lexberg AS, et al. Prevalence and severity of interstitial lung disease in mixed connective tissue disease: A nationwide, cross-sectional study. Ann Rheum Dis 2012;71:1966-72.
13. Gunnarsson R, Andreassen AK, Molberg O, Lexberg AS, Time K, Dhainaut AS, et al. Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature. Rheumatology 2013;52:1208-13.
14. Ortega-Hernandez OD, Shoenfeld Y. Mixed connective tissue disease: An overview of clinical manifestations, diagnosis and treatment. Best Pract Res Clin Rheumatol 2012;26:61-72.
15. Hoffmann-Vold AM, Midtvedt O, Molberg O, Garen T, Gran JT. Prevalence of systemic sclerosis in south-east Norway. Rheumatology 2012;51:1600-5.
16. Alhajeri H, Hudson M, Fritzler MJ, Pope JE, Canadian Scleroderma Research Group, Baron M. Evaluation of the new American College of Rheumatology/European League Against Rheumatism Criteria for the classification of systemic sclerosis in the Canadian Scleroderma Research Group Cohort [abstract]. Arthritis Rheum 2013;65 Suppl 10:S772.
17. Jordan S, Maurer B, Toniolo M, Michel B, Distler O. Performance of the new EULAR/ACR classification criteria for systemic sclerosis in clinical practice [abstract]. Ann Rheum Dis 2013;72 Suppl 3:60.
18. Mayes MD, Lacey JV Jr., Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48:2246-55.
19. Le Guern V, Mahr A, Mouthon L, Jeanneret D, Carzon M, Guillevin L. Prevalence of systemic sclerosis in a French multi-ethnic county. Rheumatology 2004;43:1129-37.
20. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972;52:148-59.
21. Prystowsky SD. Mixed connective tissue disease. West J Med 1980;132:288-93.